PCDHB15: A Potential Drug Target and Biomarker (G56121)

Target Name: PCDHB15

NCBI ID: G56121

PCDHB15

PCDHB15: A Potential Drug Target and Biomarker

PCDHB15 (Protocadherin beta 15) is a protein that is expressed in many different tissues throughout the body. It is a member of the cadherin family, which is a group of transmembrane proteins that play a critical role in cell-cell adhesion. PCDHB15 has been shown to be involved in a number of important biological processes, including cell signaling, tissue development, and regeneration.

Drug Targeting

PCDHB15 is a potential drug target because of its involvement in several diseases, including cancer, neurodegenerative diseases, and developmental disorders. One of the main reasons for its potential as a drug target is its high expression level in many different tissues, which means that it is likely to be expressed in a variety of disease-related samples, making it an attractive target for researchers to study.

Another reason why PCDHB15 is a promising drug target is its role in several key biological processes that are important for human health, such as cell signaling, tissue development, and regeneration. For example, PCDHB15 has been shown to be involved in the development and maintenance of tissues, such as the placenta and the liver, which are important for maintaining the health and function of the body.

Additionally, PCDHB15 has also been shown to be involved in several neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells, which can lead to a range of symptoms, including cognitive decline and behavioral changes. By targeting PCDHB15, researchers may be able to develop new treatments for these conditions.

Biomarker

PCDHB15 has also been shown to be a potential biomarker for several diseases, including cancer. This is because its expression has been shown to be associated with the development and progression of several types of cancer, including breast, ovarian, and prostate cancer. By detecting PCDHB15 in cancer cells, researchers may be able to use it as a diagnostic marker for these conditions, and as a target for cancer treatments.

Another potential use of PCDHB15 as a biomarker is its role in tissue engineering and regeneration. Because PCDHB15 is involved in the development and maintenance of tissues, it may be useful as a target for drugs that are designed to stimulate tissue regeneration after injury or disease. This could be an important application for drugs that are used to treat a range of conditions, including burn injuries, trauma, and diseases that affect the immune system.

Conclusion

PCDHB15 is a protein that is expressed in many different tissues throughout the body and is involved in a number of important biological processes, including cell signaling, tissue development, and regeneration. As a result, it is a potential drug target and a promising biomarker for a range of diseases. Further research is needed to fully understand the role of PCDHB15 in these processes and to develop new treatments for the conditions associated with its expression.

Protein Name: Protocadherin Beta 15

Functions: Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain

The "PCDHB15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PCDHB15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets